HEADER DE NOVO PROTEIN 17-NOV-03 1RIJ TITLE E6-BIND TRP-CAGE (E6APN1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: E6APN1 PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED KEYWDS TRP-CAGE, E6-BINDING DOMAIN, HUMAN PAPILLOMAVIRUS, HPV E6 PROTEIN, DE KEYWDS 2 NOVO PROTEIN EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR Y.LIU,Z.LIU,E.ANDROPHY,J.CHEN,J.D.BALEJA REVDAT 3 02-MAR-22 1RIJ 1 REMARK REVDAT 2 24-FEB-09 1RIJ 1 VERSN REVDAT 1 03-AUG-04 1RIJ 0 JRNL AUTH Y.LIU,Z.LIU,E.ANDROPHY,J.CHEN,J.D.BALEJA JRNL TITL DESIGN AND CHARACTERIZATION OF HELICAL PEPTIDES THAT INHIBIT JRNL TITL 2 THE E6 PROTEIN OF PAPILLOMAVIRUS. JRNL REF BIOCHEMISTRY V. 43 7421 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 15182185 JRNL DOI 10.1021/BI049552A REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CNS 1.1 REMARK 3 AUTHORS : BRUKER BIOSPIN GMBH (XWINNMR), BRUNGER, ET AL. REMARK 3 (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RIJ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1000020773. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 278 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NO SALTS REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 5.0 ~ 6.0MM PEPTIDE, PH 6.5, 90% REMARK 210 H2O, 10% D2O; 5.0 ~ 6.0MM REMARK 210 PEPTIDE, PH 6.5, 99.96% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY; 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : AMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.5, CNS 1.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 30 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : ALL CALCULATED STRUCTURES REMARK 210 SUBMITTED REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 24 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 6 H LEU A 10 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 ASP A 12 32.71 -96.92 REMARK 500 3 PRO A 22 88.76 -57.55 REMARK 500 4 PRO A 22 93.48 -43.33 REMARK 500 5 PRO A 22 77.78 -64.50 REMARK 500 7 PRO A 22 92.23 -42.25 REMARK 500 8 ASP A 12 37.42 -98.86 REMARK 500 8 PRO A 22 76.13 -63.78 REMARK 500 9 ASP A 12 30.56 -97.00 REMARK 500 9 PRO A 22 76.15 -67.57 REMARK 500 13 ASP A 12 35.18 -99.28 REMARK 500 13 PRO A 22 74.14 -69.52 REMARK 500 15 PRO A 22 86.14 -60.67 REMARK 500 17 ASP A 12 41.58 -99.19 REMARK 500 19 ASP A 12 33.81 -99.62 REMARK 500 21 LEU A 2 -60.11 -99.39 REMARK 500 23 ASP A 12 35.56 -98.66 REMARK 500 24 PRO A 22 99.92 -48.06 REMARK 500 25 ASP A 12 31.42 -99.43 REMARK 500 26 ASP A 12 39.92 -99.70 REMARK 500 26 PRO A 22 47.23 -82.71 REMARK 500 27 ASP A 12 40.09 -98.75 REMARK 500 29 PRO A 22 -164.35 -64.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RIK RELATED DB: PDB REMARK 900 RELATED ID: 1RIM RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE PEPTIDE WAS N-TERMINALLY ACETYLATED REMARK 999 AND C-TERMINALLY AMIDATED, THE COORDINATES REMARK 999 DO NOT REFLECT THESE MODIFICATIONS DBREF 1RIJ A 1 23 PDB 1RIJ 1RIJ 1 23 SEQRES 1 A 23 ALA LEU GLN GLU LEU LEU GLY GLN TRP LEU LYS ASP GLY SEQRES 2 A 23 GLY PRO SER SER GLY ARG PRO PRO PRO SER HELIX 1 1 ALA A 1 ASP A 12 1 12 HELIX 2 2 GLY A 13 GLY A 18 5 6 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1